Cookson Peirce & CO Inc Tg Therapeutics, Inc. Transaction History

Cookson Peirce & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	BUY	$33.37 - $45.51 $80,888 - $110,316	2,424 Added 7.4%	35,166 $1.27 Million
Q1 2025 May 13, 2025	BUY	$27.67 - $42.99 $128,969 - $200,376	4,661 Added 16.6%	32,742 $1.29 Million
Q4 2024 Feb 06, 2025	BUY	$21.31 - $35.09 $228,400 - $376,094	10,718 Added 61.73%	28,081 $845,000
Q3 2024 Nov 12, 2024	BUY	$17.21 - $25.28 $298,817 - $438,936	17,363 New	17,363 $406,000

397

92.6M

1.77M

1.9M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.5B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.